Table 2.
Comparisons between attention training and standard care groups for the primary outcomes: functionality in activities of daily living and quality of life
| Baseline versus 6 months | 6 versus 12 months | Baseline versus 12 months | |||||||||
| Score | Attention | Standard | p | Attention | Standard | p | Attention | Standard | p | ||
| range | training | care | training | care | training | care | |||||
| Activities of Daily Living (preserved items) | Δs# | 0–6 | 0.1±0.3 | 0±0 | 0.145 | –0.1±0.4 | –0.2±0.7 | 0.618 | 0±0.9 | –0.2±0.7 | 0.262 |
| Instrumental Activities of Daily Living | Δs# | 0–8 | –0.4±1.1 | 0±0.9 | 0.240 | –0.3±1.3 | –1±1.7 | 0.134 | –0.7±1.1 | –1±1.7 | 0.457 |
| (impaired items) | |||||||||||
| Disability Assessment in Dementia | Δs# | 0–40 | –2.2±10.3 | –3.9±11.3 | 0.612 | –6.2±20.2 | –3±11.1 | 0.522 | –8.4±21.1 | –6.9±17.2 | 0.800 |
| Attention Questionnaire | Δs# | 0–36 | –1.3±7.8 | 2.1±9.3 | 0.204 | –3.8±7.9 | –3.3±5 | 0.810 | –5.1±8.4 | –1.2±10.6 | 0.193 |
| EuroQol (summary index) | Δs# | –1/+1 | 0.1±0.2 | 0.1±0.2 | 0.698 | –0.1±0.2 | 0±0.2 | 0.283 | 0±0.3 | 0.1±0.3 | 0.647 |
| EuroQol (visual scale) | Δs# | 0–100 | 5.2±15.3 | –2.3±9.2 | 0.057 | –0.2±12.9 | –2±15.8 | 0.685 | 5±14.2 | –4.3±16.6 | 0.056 |
| Geriatric Depression Scale | Δs# | 0–15 | –0.1±2.1 | –0.8±2.9 | 0.393 | 0±2.7 | 0±2.9 | 0.958 | –0.1±2.9 | –0.7±2.5 | 0.448 |
| Mental Component Summary (SF-36) | Δs# | 0–100 | 1.4±5.3 | 3±11.4 | 0.567 | –0.1±6.2 | –2.8±9.3 | 0.274 | 1.3±7 | 0.2±9.6 | 0.668 |
| Stable/better* | 19 (100%) | 19 (86%) | 0.095 | 18 (86%) | 18 (82%) | 0.729 | 18 (95%) | 17 (77%) | 0.115 | ||
| Physical Component Summary (SF-36) | Δs# | 0–100 | –1.1±6.5 | –1.9±8.2 | 0.709 | –0.9±6.6 | 0.5±8.3 | 0.567 | –2±8.1 | –1.5±10.2 | 0.867 |
| Stable/better* | 16 (84%) | 17 (77%) | 0.576 | 16 (76%) | 20 (91%) | 0.191 | 14 (74%) | 17 (77%) | 0.790 | ||
SF-36 : 36-Item Short Form Health Survey. #A positive Δ score indicates improvement (Δs approach); independent sample t tests. *Percentages of patients having a stable or better evaluation (clinically significance approach); chi square tests.